• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Pfizer

edit

Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company applies science and its global resources to improve health and well-being at every stage of life. Pfizer’s diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and many consumer health care products. The Company operates in two business segments: Biopharmaceutical and Diversified. Biopharmaceutical includes the Primary Care, Specialty Care, Established Products, Emerging Markets and Oncology customer-focused units. Diversified includes Animal Health products that prevent and treat diseases in livestock and companion animals, and Consumer Healthcare products. On October 15, 2009, the Company completed its acquisition of Wyeth. In December 2009, Durata Therapeutics, Inc. acquired Vicuron Pharmaceuticals from Pfizer.

Milestones

edit

• 
  Pfizer added Frank A. D'Amelio as CFO.
  Posted 9/7/09 at 5:43pm
• 
  Pfizer added Jeffrey B. Kindler as CEO.
  Posted 9/7/09 at 5:43pm
• 
  Pfizer invested in Clovis Oncology. (6/6/11)
  Posted 6/6/11 at 8:17pm via dowjones.com
• 
  Pfizer invested in Merus. (1/29/10)
  Posted 1/31/10 at 8:46pm via merus.nl
• 
  Pfizer invested in Aureon Laboratories. (4/14/10)
  Posted 4/25/10 at 8:32am via onbiovc.com
• 
  Went public with stock symbol NYSE:PFE.
  Posted 9/6/10 at 10:46pm
• 
  Pfizer acquired ICAgen for $56M. (10/28/11)
  Posted 7/20/11 at 8:03pm via dowjones.com
• 
  Pfizer acquired King Pharmaceuticals for $3.6B. (10/12/10)
  Posted 11/23/10 at 2:14pm via fiercebiotech.com
• 
  Pfizer acquired Foldrx Pharmaceuticals. (9/1/10)
  Posted 9/6/10 at 10:47pm via foldrx.com
• 
  Pfizer acquired Encysive Pharmaceuticals for $195M. (2/20/08)
  Posted 9/7/09 at 5:45pm via marketwatch.com
• 
  Pfizer — Pfizer ups ante on Santaris RNA discovery deal with $614M pact (1/4/11)
  Posted 1/16/11 at 11:25pm via fiercebiotech.com
• 
  Pfizer — has established a new network of academic centers that will serve as a “farm team” for drug development. (11/16/10)
  Posted 11/16/10 at 10:07am via masshightech.com
• 
  Pfizer — Pfizer ends brain cancer vaccine deal with Celldex (9/3/10)
  Posted 9/7/10 at 4:19am via masshightech.com

Videos

Screenshots

edit

Stock Price

Sources

1. Pfizer Acquires Icagen, Ends Fight By Two Venture Investors (fis.dowjones.com) [edit]
2. Pfizer takes King in $3.6B pain gambit (fiercebiotech.com) [edit]
3. Pfizer To Acquire FoldRx Pharmaceuticals (foldrx.com) [edit]
4. Pfizer to buy Encysive for $195 million (marketwatch.com) [edit]
5. Clovis Oncology Sees $20M From Pfizer To Develop Anti-Tumor Meds (fis.dowjones.com) [edit]
6. onbiovc.com [edit]
7. Merus closes EUR 21.7 million Series B financing and enters option agreement with the Novartis Option Fund (merus.nl) [edit]
8. Pfizer ends brain cancer vaccine deal with Celldex (masshightech.com) [edit]
9. New Pfizer academic-industrial program based in Cambridge (masshightech.com) [edit]
10. Pfizer ups ante on Santaris RNA discovery deal with $614M pact (fiercebiotech.com) [edit]